Enhabit (NYSE:EHAB) Announces Earnings Results, Misses Estimates By $0.03 EPS

Enhabit (NYSE:EHAB - Get Free Report) announced its quarterly earnings results on Wednesday. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.03), Zacks reports. The business had revenue of $258.20 million during the quarter, compared to analysts' expectations of $259.11 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. Enhabit updated its FY 2025 guidance to 0.410-0.510 EPS.

Enhabit Price Performance

EHAB traded up $0.51 on Friday, reaching $8.53. 487,962 shares of the company's stock were exchanged, compared to its average volume of 296,526. Enhabit has a twelve month low of $6.85 and a twelve month high of $11.74. The stock has a market cap of $428.67 million, a PE ratio of -3.67 and a beta of 1.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. The stock's fifty day moving average price is $8.20 and its 200-day moving average price is $7.91.

Analysts Set New Price Targets

A number of research firms recently issued reports on EHAB. Jefferies Financial Group raised shares of Enhabit from a "hold" rating to a "buy" rating and lifted their price target for the company from $8.25 to $9.50 in a research note on Monday, December 9th. Leerink Partners reissued a "market perform" rating and set a $8.00 target price (down previously from $8.50) on shares of Enhabit in a report on Tuesday, November 19th.

Remove Ads

Insider Buying and Selling at Enhabit

In related news, Director Stuart M. Mcguigan bought 15,000 shares of the company's stock in a transaction on Tuesday, December 10th. The stock was bought at an average cost of $8.81 per share, for a total transaction of $132,150.00. Following the acquisition, the director now directly owns 46,810 shares in the company, valued at $412,396.10. This represents a 47.15 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Jeffrey Bolton purchased 4,000 shares of Enhabit stock in a transaction dated Thursday, December 12th. The shares were bought at an average price of $8.69 per share, for a total transaction of $34,760.00. Following the acquisition, the director now owns 98,144 shares in the company, valued at approximately $852,871.36. This trade represents a 4.25 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.90% of the stock is owned by insiders.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.